Sort
15,842 grants matching “pancreatic cancer”
Inhibition of Pancreatic Cancer by New PPARgamma Agonis*
$210,424Stephen H Safe · Texas A&M University · R01 · FY2006 · CA
Adoption and Retooling of GEM model for Pancreatic Cancer
$210,366Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development of ES/iPSC approach for non-germline GEM modeling
$210,366Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Selective inhibition of COPZ1 in PDAC cells
$210,357Roberto Gomes · North Dakota State University · P20 · FY2022 · GM
Multi-omic marker sets involving KRAS, TP53, and SMAD4 and their association with survival in pancreatic ductal adenocarcinoma
$210,357Rick J Jansen · North Dakota State University · P20 · FY2022 · GM
Real-time PCR expression profiling of microRNA
$210,183Thomas D Schmittgen · Ohio State University · R21 · FY2006 · CA
Mechanism of RelA activation in Pancreatic cancer
$210,118Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Cross Regulation of TGFB/elf, B-catenin and Vitamin D Pathways in Gastrointestina
$210,097Stephen W Byers · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Project 2: Endoscopic Photodynamic and Combination Therapy for Local and Metastatic Pancreatic Tumors
$210,082Stephen Pereira · Massachusetts General Hospital · P01 · FY2018 · CA
Southwest Oncology Group
$210,028Lawrence E Flaherty · Wayne State University · U10 · FY2007 · CA
'Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis
$209,999Anna S Gukovskaya · University Of California Los Angeles · P01 · FY2012 · CA
Imaging Nuclear Receptor LRH-1 in Functional Transcriptional Assemblies
$209,989Robert J Fletterick · University Of California, San Francisco · R21 · FY2009 · DK
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.
$209,986Craig Patrick Ramirez · Tezcat Laboratories Llc · R41 · FY2022 · CA
Mutant mouse models of exocrine pancreatic cancer
$209,928David Tuveson · Cancer Research United Kingdom · R01 · FY2007 · CA
Mutant mouse models of exocrine pancreatic cancer
$209,928David Tuveson · Cancer Research United Kingdom · R01 · FY2008 · CA
Research Project 1
$209,904Cynthia X Ma · Washington University · U54 · FY2025 · CA
Research Project 2
$209,902Kian H Lim · Washington University · U54 · FY2025 · CA
Next-Generation Antibody Discovery and Development Technology
$209,825David Scott Johnson · Gigagen, Inc. · R44 · FY2018 · CA
Multiplexed in vivo drug screening: Inhibitors of metastatic seeding
$209,745Monte Meier Winslow · Stanford University · R21 · FY2014 · CA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$209,717Valerie Humblet · Collagen Medical, Llc · R44 · FY2018 · CA
Pancreas Cancer Specialized Program of Research Excelle*
$209,700Anton Wellstein · Georgetown University · R01 · FY2007 · CA
Clinical Tissue Procurement and Sequencing Core
$209,671Cathy D Vocke · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
CD95 (FAS) LIGAND AND IMMUNE PRIVILEGED TISSUE
$209,573Eleanor Roosevelt Inst For Cancer Res · R01 · FY2000 · AI
SPORE IN GASTROINTESTINAL CANCER
$209,540Johns Hopkins University · P50 · FY2001 · CA
Cellular Interations of TGS-B Pathyway Members and Regulators of Foregut Cancers
$209,515Lopa Mishra · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA